What Key Growth Drivers Are Shaping The Endotoxin Testing Market Forecast Toward $2.91 Billion?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Big Is The Endotoxin Testing Market Today And What Is Its Future Size?
In recent times, the size of the endotoxin testing market has seen consistent growth. It is projected that the market will expand from a worth of $2.24 billion in 2024 to $2.31 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 3.4%. The growth during the historic period is linked to a rise in demand for biologics and biosimilars, an enhanced understanding of the significance of endotoxin testing, and an increase in the incidences of infectious diseases.
The market size for endotoxin testing is projected to witness substantial growth in the upcoming years, expanding to $2.91 billion by 2029 with a compound annual growth rate (CAGR) of 5.9%. This expansion during the forecast period can be ascribed to the growth of the biopharmaceutical sector, escalating investments in endotoxin testing research and development, and the broadening of global healthcare. Significant trends forecasted for this period include the development of cutting-edge endotoxin detection tools, the incorporation of endotoxin testing services, and an increased demand for these services.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12932&type=smp
Which Demand Drivers Are Strengthening The Endotoxin Testing Market?
The acceleration in the endotoxin testing market is expected to be fueled by the rising cases of healthcare-associated infections. These infections are typically contracted while obtaining medical treatment and were initially non-existent at the hospital admission time. Contaminated medical equipment or procedures often cause these infections, hence necessitating thorough testing to assure the safety of the patients. Endotoxin testing services play a vital role in lessening such infections by evaluating the bacterial endotoxin levels in medical equipment, predominantly injectable pharmaceutical goods and implantable medical devices. To illustrate, in December 2022, the United Nations International Children’s Emergency Fund (UNICEF), a US-based United Nations agency, reported that pneumonia was the top child-killer infectious disease, claiming over 700,000 children’s lives yearly or around 2,000 daily. Furthermore, the World Health Organization, a Switzerland-based United Nations agency, reported in May 2022 that healthcare-associated sepsis affects 24% of patients yearly and 52.3% of those treated in an intensive care unit succumb to it each year. Therefore, the escalating cases of healthcare-associated infections are propelling the growth of the endotoxin testing market.
Which Segment Accounts For The Largest Share In The Endotoxin Testing Market?
The endotoxin testingmarket covered in this report is segmented –
1) By Test Type: LAL (Limulus Amebocyte Lysate) Test; Chromogenic Tests; Turbidimetric Tests; Gel Clot Tests; MAT Test; Rabbit Pyrogen Test; Recombinant Factor C (rFC) Assay
2) By Application: Medical Devices; Pharmaceuticals; Packaging; Raw Materials
3) By End-User: Hospitals; Laboratories; Research Institutes
Subsegments:
1) By LAL (Limulus Amebocyte Lysate) Test: Gel Clot LAL Test; Kinetic LAL Test; Endpoint LAL Test
2) By Chromogenic Tests: Chromogenic LAL Test; Chromogenic Factor C Assay
3) By Turbidimetric Tests: Turbidimetric LAL Test; Turbidimetric Factor C Assay
4) By Gel Clot Tests: Gel Clot LAL Test
5) By MAT Test (Monocyte Activation Test): Direct MAT; Indirect MAT
6) By Rabbit Pyrogen Test: Standard Rabbit Pyrogen Test
7) By Recombinant Factor C (rFC) Assay: RFC Assay For Endotoxin Detection
What Strategic Shifts And Innovations Are Influencing The Endotoxin Testing Market?
Major players in the endotoxin testing market are striving to adopt new technological solutions to maintain their market share. For instance, in August 2023, Suisse’s pharmaceutical, biotechnology, and nutrition manufacturing firm Lonza Group AG, introduced the Nebula absorbance reader, a novel absorbance microplate reader designed to streamline endotoxin and pyrogen testing. The reader comes fully integrated with Lonza’s latest WinKQCL software. This integration not only eases data integrity compliance and accelerates training, but it also reduces the validation load. The need for WinKQCL software users to acquaint themselves with new software to use the new reader is eliminated, thus lowering training requirements. The Nebula Absorbance Reader represents an innovative, technologically superior replacement reader that yields results aligning with those typically seen with the ELx808, the established standard absorbance reader that Lorenz no longer sells. Furthermore, it’s crafted to be compatible with and meet the stringent demands of Lonza’s absorbance-based endotoxin tests, such as the Lonza PYROGENT 5000 Turbidimetric and Kinetic-QCL Chromogenic Endotoxin Assays.
Which Companies Hold A Competitive Edge In The 583 Market?
Major companies operating in the endotoxin testing market are Thermo Fisher Scientific Inc., Merck KGaA, bioMérieux SA., Eurofins Scientific SE, Lonza Group Ltd., WuXi AppTec Co. Ltd., Bio-Rad Laboratories Inc., Maravai LifeSciences Holdings Inc., Cambrex Corporation, GenScript Biotech Corporation, Charles River Laboratories International Inc., Nelson Laboratories LLC, Lifecore Biomedical Inc., Stellar Biotechnologies Inc., Biovision Inc., Associates of Cape Cod Inc., FUJIFILM Wako Pure Chemical Corporation, InvivoGen Inc., Tebu-bio Nv., MatTek Corporation, Microcoat Biotechnologie GmbH, Accelagen Inc., BioAssay Systems LLC, BioThema AB, Hycult Biotech Inc., Pacific Biolabs Inc., Xiamen Bioendo Technology Co. Ltd., Zhanjiang A&C Biological Ltd., Accugen Laboratories Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/endotoxin-testing-global-market-report
Which Region Is Forecasted To Lead The Endotoxin Testing Market In The Coming Years?
North America was the largest region in the endotoxin testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in endotoxin testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12932&type=smp
Browse Through More Reports Similar to the Global Endotoxin Testing Market 2025, By The Business Research Company
Hospital Acquired Infections Testing Kits Global Market Report 2025
Non Animal Alternatives Testing Global Market Report 2025
Pharma Microbiology Testing Kits Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
